Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,553
Total Claims
$1.2M
Drug Cost
3,432
Beneficiaries
$346
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-71%
Cost per patient vs peers
$346 vs $1,174 avg
+7%
Brand preference vs peers
9.5% vs 8.9% avg
Brand vs Generic
Brand: 1,085 claims · $942K
Generic: 10,324 claims · $241K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 80 | $99K |
| Sitagliptin Phosphate | 45 | $65K |
| Semaglutide | 35 | $62K |
| Bictegrav/Emtricit/Tenofov Ala | 13 | $53K |
| Empagliflozin | 47 | $52K |
| Insulin Detemir | 14 | $43K |
| Fluticasone Propion/Salmeterol | 41 | $39K |
| Budesonide/Formoterol Fumarate | 26 | $22K |
| Linagliptin | 20 | $22K |
| Tiotropium Bromide | 14 | $18K |
| Dapagliflozin Propanediol | 11 | $18K |
| Insulin Aspart | 18 | $18K |
| Atorvastatin Calcium | 1,294 | $16K |
| Rivaroxaban | 12 | $15K |
| Levothyroxine Sodium | 565 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
61%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data